Additional Locations, Ohio Clinical Trials

A listing of Additional Locations, Ohio clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia

This project aims to implement a multi-level group randomized trial, delayed intervention that includes components targeting clinics, providers, patients, and the community to increase colorectal cancer (CRC) screening, follow-up, and referral-to-care among patients age 50-74 in 12 counties in Appalachian Kentucky and Ohio. The 12 counties will be assigned to …

screening for colorectal cancer
cancer screening
colorectal cancer
colorectal cancer screening
Ohio State University
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 …

multiple sclerosis
secondary progressive multiple sclerosis
contraceptive use
chronic progressive multiple sclerosis
Investigational Site Number 8400010
 (5.2 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +15 other locations
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)

Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety …

oligoclonal bands
multiple sclerosis
Investigational Site Number 8400147
 (7.9 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +14 other locations
Black Raspberry Nectar for the Prevention of Lung Cancer BE WELL Study

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

vitamins
cancer
carcinoma
lung cancer
lung carcinoma
Ohio State University Comprehensive Cancer Center
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

anaplastic lymphoma
small cell lung cancer
measurable disease
lung cancer
solid tumor
The Ohio State University - The James /ID# 212298
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

anticonvulsants
melanoma
HRAS
recurrent hepatoblastoma
solid tumors
Nationwide Children's Hospital
 (7.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors

This trial studies the benefits of an exercise and diet counseling program in improving quality of life in stage I-III breast cancer survivors. Exercise and diet counseling may help improve weight loss and relevant clinical and patient-reported outcomes in overweight or obese breast cancer survivors.

prognostic stage iiib breast cancer ajcc v8
anatomic stage ia breast cancer ajcc v8
anatomic stage ii breast cancer ajcc v8
anatomic stage iiic breast cancer ajcc v8
prognostic stage iia breast cancer ajcc v8
Ohio State University Comprehensive Cancer Center
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

covid-19
acute respiratory syndrome (sars)
pneumonia
ct scan
SARS
The Ohio State University Wexner Medical Center
 (6.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +13 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840091
 (7.0 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +124 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

replacement therapy
deficiency
fabry's disease
alpha-galactosidase
fabrazyme
Investigational Site Number 840097
 (6.5 away) Contact site
  • 0 views
  • 22 Dec, 2020
  • +125 other locations